Drug Type RNA aptamer |
Synonyms |
Target |
Action inhibitors |
Mechanism C5a inhibitors(complement C5a inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Community Acquired Pneumonia | Phase 2 | Belgium | 02 Feb 2024 | |
Community Acquired Pneumonia | Phase 2 | France | 02 Feb 2024 | |
Community Acquired Pneumonia | Phase 2 | Germany | 02 Feb 2024 | |
Community Acquired Pneumonia | Phase 2 | United Kingdom | 02 Feb 2024 | |
Community Acquired Pneumonia | Phase 2 | Spain | 02 Feb 2024 | |
Lung Cancer | Phase 1 | Germany | 25 Aug 2022 | |
Hemoglobinuria, Paroxysmal | Preclinical | Germany | 07 Dec 2017 | |
Hemoglobinuria, Paroxysmal | Preclinical | United States | 07 Dec 2017 |